Stripp Diana C H, Maity Amit, Janss Anna J, Belasco Jean B, Tochner Zelig A, Goldwein Joel W, Moshang Thomas, Rorke Lucy B, Phillips Peter C, Sutton Leslie N, Shu Hui-Kuo G
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):714-20. doi: 10.1016/S0360-3016(03)01570-0.
The optimal management of craniopharyngiomas remains controversial, especially in children and young adults. This study reports a single institution's experience with such patients.
Between 1974 and 2001, 76 patients were treated for craniopharyngioma at the Children's Hospital of Philadelphia and the Hospital of University of Pennsylvania (HUP). Of these, 75 patients (97%) were evaluable with long-term follow-up. Although all patients underwent attempted gross total resection, 27 had documentation of less than total resection with 18 of these patients receiving immediate postoperative radiotherapy (RT). An additional 22 patients received RT at HUP after failing surgery alone.
Median follow-up for all patients was 7.6 years. The 10-year actuarial overall survival, relapse-free survival, and local control (LC) rates for all patients were 85%, 48%, and 53%, respectively. When comparing the 57 patients treated with surgery alone to the 18 treated with subtotal resection (STR) followed by RT, a significant difference in LC rates at 10 years (42% vs. 84%, respectively; p = 0.004) was noted. However, no statistically significant difference in overall survival was found between the two groups, because RT was highly effective as salvage therapy. Twenty-two patients at HUP treated with RT after relapse had a 10-year ultimate LC rate comparable to that of patients who received RT immediately after STR.
RT given either immediately after STR or at relapse is effective in controlling craniopharyngiomas.
颅咽管瘤的最佳治疗方案仍存在争议,尤其是在儿童和年轻成人中。本研究报告了单一机构对这类患者的治疗经验。
1974年至2001年间,费城儿童医院和宾夕法尼亚大学医院(HUP)对76例颅咽管瘤患者进行了治疗。其中75例患者(97%)可进行长期随访评估。尽管所有患者均尝试进行全切除,但27例患者记录为未完全切除,其中18例患者术后立即接受了放疗(RT)。另外22例患者在单纯手术失败后于HUP接受了放疗。
所有患者的中位随访时间为7.6年。所有患者的10年精算总生存率、无复发生存率和局部控制(LC)率分别为85%、48%和53%。将57例单纯接受手术治疗的患者与18例接受次全切除(STR)后放疗的患者进行比较时,发现10年时的LC率存在显著差异(分别为42%和84%;p = 0.004)。然而,两组之间的总生存率没有统计学上的显著差异,因为放疗作为挽救性治疗非常有效。22例在复发后接受放疗的HUP患者的10年最终LC率与STR后立即接受放疗的患者相当。
STR后立即放疗或复发时放疗对控制颅咽管瘤有效。